These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 32021437)

  • 1. Immune-Ageing Evaluation of Peripheral T and NK Lymphocyte Subsets in Chinese Healthy Adults.
    Jia Z; Ren Z; Ye D; Li J; Xu Y; Liu H; Meng Z; Yang C; Chen X; Mao X; Luo X; Yang Z; Ma L; Deng A; Li Y; Han B; Wei J; Huang C; Xiang Z; Chen G; Li P; Ouyang J; Chen P; Luo OJ; Gao Y; Yin Z
    Phenomics; 2023 Aug; 3(4):360-374. PubMed ID: 37589027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A score-based method of immune status evaluation for healthy individuals with complete blood cell counts.
    Zhang M; Zhao C; Cheng Q; Xu J; Xu N; Yu L; Feng W
    BMC Bioinformatics; 2023 Dec; 24(1):467. PubMed ID: 38082403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 4. Establishing immune scoring model based on combination of the number, function, and phenotype of lymphocytes.
    Tang G; Yuan X; Luo Y; Lin Q; Chen Z; Xing X; Song H; Wu S; Hou H; Yu J; Mao L; Liu W; Wang F; Sun Z
    Aging (Albany NY); 2020 May; 12(10):9328-9343. PubMed ID: 32396527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes and Clinical Significance of Detailed Peripheral Lymphocyte Subsets in Evaluating the Immunity for Cancer Patients.
    Qiu J; Zhou F; Li X; Zhang S; Chen Z; Xu Z; Lu G; Zhu Z; Ding N; Lou J; Ye Z; Qian Q
    Cancer Manag Res; 2020; 12():209-219. PubMed ID: 32021437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Shifting in T-helper and T-cytotoxic Subset Cell Population in Mild and Severe COVID-19 Patients Infected With Variant B.1.61.
    Agarwal J; Awasthi NP; Singh S; Tiwari V
    Cureus; 2023 Jun; 15(6):e40556. PubMed ID: 37465793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte Subsets in Defense Against New Pathogens in Patients with Cancer.
    Arango-Prado MDC; Villegas-Valverde CA; Torres-López G; Soto-Pardeiro P; Suárez-Reyes A; Faxas-García ME; Diéguez-Rodríguez V; Gracia-Medina E; Esperón-Noa R; Del Castillo-Bahi R; Méndez-Rosabal A; Curbelo-Alfonso L
    MEDICC Rev; 2022 May; 24(2):26-34. PubMed ID: 35648060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients with a failed metal-on-metal hip implant with a pseudotumor present differences in their peripheral blood lymphocyte subpopulations?
    Catelas I; Lehoux EA; Hurda I; Baskey SJ; Gala L; Foster R; Kim PR; Beaulé PE
    Clin Orthop Relat Res; 2015 Dec; 473(12):3903-14. PubMed ID: 26324830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    Hjorth M; Dandu N; Mellergård J
    PLoS One; 2020; 15(2):e0228380. PubMed ID: 32012202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer.
    Yang P; Ma J; Yang X; Li W
    Oncotarget; 2017 Oct; 8(48):83650-83659. PubMed ID: 29137371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer.
    Singh N; Shi J; June CH; Ruella M
    Curr Hematol Malig Rep; 2017 Dec; 12(6):522-529. PubMed ID: 29039115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.
    DeFalco J; Harbell M; Manning-Bog A; Baia G; Scholz A; Millare B; Sumi M; Zhang D; Chu F; Dowd C; Zuno-Mitchell P; Kim D; Leung Y; Jiang S; Tang X; Williamson KS; Chen X; Carroll SM; Espiritu Santo G; Haaser N; Nguyen N; Giladi E; Minor D; Tan YC; Sokolove JB; Steinman L; Serafini TA; Cavet G; Greenberg NM; Glanville J; Volkmuth W; Emerling DE; Robinson WH
    Clin Immunol; 2018 Feb; 187():37-45. PubMed ID: 29031828
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.